284 related articles for article (PubMed ID: 8247013)
1. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
[TBL] [Abstract][Full Text] [Related]
2. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.
Hao E; Menke JB; Smith AM; Jones C; Geffner ME; Hershman JM; Wuerth JP; Samuels HH; Ways DK; Usala SJ
Mol Endocrinol; 1994 Jul; 8(7):841-51. PubMed ID: 7984146
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
[TBL] [Abstract][Full Text] [Related]
4. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.
Usala SJ; Menke JB; Watson TL; Wondisford FE; Weintraub BD; Bérard J; Bradley WE; Ono S; Mueller OT; Bercu BB
Mol Endocrinol; 1991 Mar; 5(3):327-35. PubMed ID: 1653889
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.
Ulisse S; Esslemont G; Baker BS; Krishna V; Chatterjee K; Tata JR
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1205-9. PubMed ID: 8577741
[TBL] [Abstract][Full Text] [Related]
6. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
Takeda T; Suzuki S; Liu RT; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
[TBL] [Abstract][Full Text] [Related]
7. Repression of c-fos gene expression by thyroid hormone and retinoic acid receptors.
Perez P; Schönthal A; Aranda A
J Biol Chem; 1993 Nov; 268(31):23538-43. PubMed ID: 8226882
[TBL] [Abstract][Full Text] [Related]
8. An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.
Geffner ME; Su F; Ross NS; Hershman JM; Van Dop C; Menke JB; Hao E; Stanzak RK; Eaton T; Samuels HH
J Clin Invest; 1993 Feb; 91(2):538-46. PubMed ID: 8381821
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
[TBL] [Abstract][Full Text] [Related]
10. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
11. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the rat growth hormone promoter elements required for induction by thyroid hormone with and without a co-transfected beta type thyroid hormone receptor.
Brent GA; Larsen PR; Harney JW; Koenig RJ; Moore DD
J Biol Chem; 1989 Jan; 264(1):178-82. PubMed ID: 2909514
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.
Chatterjee VK; Nagaya T; Madison LD; Datta S; Rentoumis A; Jameson JL
J Clin Invest; 1991 Jun; 87(6):1977-84. PubMed ID: 2040690
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
16. An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.
Cugini CD; Leidy JW; Chertow BS; Bérard J; Bradley WE; Menke JB; Hao EH; Usala SJ
J Clin Endocrinol Metab; 1992 May; 74(5):1164-70. PubMed ID: 1314846
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor.
Schaufele F; West BL; Baxter JD
Mol Endocrinol; 1992 Apr; 6(4):656-65. PubMed ID: 1584227
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.
Sakurai A; Miyamoto T; Refetoff S; DeGroot LJ
Mol Endocrinol; 1990 Dec; 4(12):1988-94. PubMed ID: 2082193
[TBL] [Abstract][Full Text] [Related]
19. The thyroid hormone receptor interferes with transcriptional activation via the AP-1 complex.
Schmidt ED; Cramer SJ; Offringa R
Biochem Biophys Res Commun; 1993 Apr; 192(1):151-60. PubMed ID: 8386506
[TBL] [Abstract][Full Text] [Related]
20. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
